Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 GanedenBC30 Protects Against C. diff. - Nutraceuticals World

What are you searching for?

Sign in
Research

GanedenBC30 Protects Against C. diff.

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

New research has been announced by Ganeden Biotech, Cleveland, OH, which indicated that their probiotic strain GanedenBC30 might aid in the prevention of C. difficile-induced infection (CDI). Recently published in the journal Gut Pathogens, the study demonstrated that Bacillus coagulans GBI-30, 6086 (GanedenBC30) prevents the recurrence of CDI in mice. Additionally, the study found that the mice given GanedenBC30 when re-infected with C.diff experienced more mild symptoms and recovered faster than those mice that were not given the probiotic. Dr. David Keller, vice president of scientific operations at Ganeden Biotech and one of the study’s authors explained, “Currently antibiotics are the primary weapon in the arsenal to fight C. diff. These findings show that the probiotic GanedenBC30 may provide an alternative.” 
For further information: http://www.gutpathogens.com/content/4/1/13/abstract

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics